BioNTech, Pfizer sic mRNA on the flu

BioNTech AG (Mainz, Germany) partnered with Pfizer Inc. (NYSE:PFE) to develop mRNA-based influenza vaccines, marking the biotech's first step toward building an R&D presence

Read the full 244 word article

User Sign In